Low testosterone is a real life problem that is making headlines not just in health news, but business publications are reporting the benefits of how testosterone and bioidentical hormone therapy makes its way into the boardroom.
It doesn’t matter that you are getting older—that’s no excuse on Wall Street or any other workplace anymore. Indeed, men are expected to stay at the top of their game long after they turn into silver foxes.
What’s more, in today’s economy many men have to put off retirement longer, and that means staying fit, healthy and running full speed ahead against younger men. You don’t have time for memory loss, foggy brain, or weight gain that diminishes your competitive edge. These symptoms, as well as fatigue, hair loss, insomnia, depression, and loss of muscle mass, could be signs that you are suffering from andropause.
The good news is, testosterone replacement therapy can help reverse these symptoms. The even better news is that testosterone replacement therapy is not just for the elite and super wealthy anymore. Dr. Paul Savage and his team of anti-aging physicians at Ageology in Chicago are working to make testosterone replacement therapy safe and affordable for the masses by delivering solutions at half the price of well-known hormone therapy centers.
The demand is real. A recent article in the Financial Times chronicles the rise of “Low T” among men and the clamor for treatment that has followed. Apparently, the demand is especially prevalent among Wall Street gurus. Las Vegas-based Cenegenics is opening a center offering male hormone treatments near the New York Stock Exchange. It seems Wall Street workers are concerned that if they don’t outperform their peers—think Michael Douglas in Money Never Sleeps—they will soon be looking for a new job.
According to FT writer Charles Wallace, Cenegenics offers a deluxe treatment program, but it’s so steep that perhaps only those who get a Wall Street bonus can afford it. “For a $4,000 initial fee, a nurse even comes to collect your blood in the privacy of your own home,” he writes. “The patient then spends an entire day being probed and tested for a range of ageing-related issues at one of the company’s centers—not only for hormone levels, but also for such problems as vitamin D deficiency.”
Cenegenics has 20 hormone treatment centers around the United States serving 20,000 patients. Revenues have increased from $37 million in 2007 to $60 million in 2011. Cenegenic is providing a valuable service to many on Wall Street, but Chicago’s financial gurus—and others who want to overcome the symptoms of andropause—can turn to local bioidentical hormone therapy physicians at Ageology are delivering cost-effective testosterone treatments.
“Many men look at impotence as a symptom of low testosterone levels—and that’s often the case,” Savage says. “But more men are beginning to realize that low testosterone can bring with it other symptoms that make it harder for them to compete in the workforce. With Ageology’s approach, men can find an affordable alternative to high-priced hormone replacement therapy springing up across the United States.”